Data / Form D filings / ABLi Therapeutics, Inc.
ABLi Therapeutics, Inc.: Form D filing
ABLi Therapeutics, Inc., a pharmaceuticals company in Atlanta, GA, filed a Form D with the SEC in 2026. The latest, on January 13, 2026, reports $1 million sold of a $1 million offering to 10 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 3350 RIVERWOOD PKWY SE STE 1900, Atlanta, GA, 30339
- Phone
- (917) 494-0831
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2025
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2104142
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jan 13, 2026 | New notice | $1,000,000 | $1,000,000 | 10 | Sep 15, 2025 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Milton H. Werner | Executive Officer, Director | Chief Executive Officer, President, and Secretary |
| Garth Lees-Rolfe | Executive Officer | Chief Financial Officer and Treasurer |
| Anastasia Daifotis | Director | |
| Jeffrey Young | Director |
Other pharmaceuticals companies in Georgia that filed recently
- Laurentide Therapeutics Inc. $99,999 · Sep 28, 2026
- LifeCyte Innovations, Inc. $1 million · Aug 20, 2026
Every Form D from the week of Jan 12, 2026 · All recent filings in Georgia · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what ABLi Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.